NPR logo

Gene Therapy/Open Source Software

  • Download
  • <iframe src="https://www.npr.org/player/embed/923434/923435" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Gene Therapy/Open Source Software

Gene Therapy/Open Source Software

Gene Therapy/Open Source Software

  • Download
  • <iframe src="https://www.npr.org/player/embed/923434/923435" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">


Guests:

Joseph Glorioso
* President, American Society for Gene Therapy
* Director, University of Pittsburgh Human Gene Therapy Center University of Pittsburgh School of Medicine, Pittsburgh, Penn.

Bruce Perens
* Computer Scientist and Linux developer, Berkeley, Calif.

Michael Robertson
* Founder and CEO Lindows.com, San Diego, Calif.

This week the FDA put several gene therapy trials on hold, following the announcement that two participants in similar trials had developed leukemia. Join host Ira Flatow and guests to discuss the status of gene therapy research. Plus, we'll be taking a look at the philosophy — and business — of open source software.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.